Join
Live feed
·
INSIDERFilingvia Quantisnow
Seres Therapeutics Inc. logo

Director Shaff Eric D. converted options into 722 shares and sold $1,950 worth of shares (259 units at $7.53) as part of a pre-agreed trading plan, increasing direct ownership by 4% to 12,040 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MCRB (Seres Therapeutics Inc.) and more on Quantisnow.

Director Shaff Eric D. converted options into 722 shares and sold $1,950 worth of shares (259 units at $7.53) as part of a pre-agreed trading plan, increasing direct ownership by 4% to 12,040 units (SEC Form 4) | Quantisnow